title: [Differential diagnosis and treatment of metatypic cancer].
abstract: Fifty one patients with metatypic carcinoma (MC), 10 with basalioma, and 10 with squamous cell carcinoma were clinically and immuno-morphologically studied. There were great differences in the localization of basal cell antigen in the epidermis during MC, basalioma, squamous carcinoma of the skin. Expression of fixed immunoglobulins A, M, G in tumor tissues revealed no significant differences. Fifty one patients underwent a complex treatment with prospidin in a total dose of 3,000-3,500 mg (in a daily dose of 100 mg) followed by near-focus X-ray therapy in a total dose of 3,000 Gy (a single dose being 500 Gy). Good immediate and late (the duration of the follow-up was as long as 5 years) results were obtained.
authors.forename: V A
authors.initials: VA
authors.lastname: Molochkov
authors.forename: P Iu
authors.initials: PIu
authors.lastname: Poliakov
authors.forename: V G
authors.initials: VG
authors.lastname: Fradkin
authors.forename: I A
authors.initials: IA
authors.lastname: Kazantseva
authors.forename: E S
authors.initials: ES
authors.lastname: Snarskaia
mesh_terms: D000328:Adult; D000368:Aged; D002280:Basal Cell Carcinoma / Q000175:diagnosis* / Q000628:therapy; D002281:Carcinoma, Basosquamous / Q000175:diagnosis* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000628:therapy; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000628:therapy